ReaGenics

Optimizing Nature’s Gifts: Growing plants better.

 

ABOUT US

ReaGenics is pioneering a novel plant cell bioreactor production for the mass-scale multiplication of molecules. This eliminates the need to grow plants on an industrial scale for pharma-grade, botanically- derived molecules. Leveraging success with patented technology for multiplication and manipulation of lavender cells, ReaGenics is applying the same technology to other plants allowing for consistent, controllable, and patentable formulation.

Active Markets

 

Plant Proteins

Cannabis

Herbal Medicine

Therapeudic Psychedelics

Optimizing Nature’s gifts:

Growing Plants Better

Our world urgently needs a way to keep up with the growing demands of medicines, food supply chains, and the problem of so many of the world’s plant species on their way to extinction. We believe ReaGenics will be part of the solution to ensure these global needs and challenges are met.

By harnessing ancient knowhow from the Far-East, Africa, and Europe and applying cutting edge technologies, ReaGenics aims to disrupt the biotech industry and forever plant its footprint in global ecology.

WHO WE ARE

ReaGenics Research is an Israeli company focused on R&D rooted in cell tissue culturing aiming to be a market leader for a range of nutraceutical, food, pharmaceutical, medical and wellness products.

WHAT WE DO

ReaGenics is developing a technology platform that efficiently and safely grows to scale organic plant molecules in bioreactors.

Most Innovative
Global Cannabinoid Company

2020

Most Disruptive
Global Biotech Company

2021

Interested?

ReaGenics

3 Pinchas

Nes Tsiona, Israel

Our partners